stockrowTwist Bioscience Corporation
TWST Healthcare Biotechnology
Twist Bioscience Corporation’s revenue for fiscal 2025 (year ended September 2025) was $376.6 million, up 20.3% from fiscal 2024.
- Revenue
- +23.2%
- EPS
- −264.7%
- Free cash flow
- −7.23%
- Total debt
- 0.00%
Quarter to June 2026, against a year earlier
Follow TWST
Alert me
Twist Bioscience Corporation (TWST) Book value per share
Twist Bioscience Corporation's book value per share at the end of fiscal 2025 was 7.9×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 7.1×. Over the past ten years it has ranged from 0.0× (fiscal 2016) to 31.9× (fiscal 2018); the current reading is higher than 30% of that period. Twist Bioscience Corporation ranks 112th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 7.9× | (2.94%) |
| FY2024 | 8.1× | (25.66%) |
| FY2023 | 11.0× | (25.19%) |
| FY2022 | 14.6× | 21.70% |
| FY2021 | 12.0× | 40.29% |
| FY2020 | 8.6× | 54.94% |
| FY2019 | 5.5× | (82.63%) |
| FY2018 | 31.9× | 16.53% |
| FY2017 | 27.4× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 7.1× | (3.16%) |
| Mar 2026 | 7.4× | (1.23%) |
| Dec 2025 | 7.5× | (5.57%) |
| Sep 2025 | 7.9× | (0.79%) |
| 33 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| KRYS Krystal Biotech, Inc. compare | 48.5× |
| MDGL Madrigal Pharmaceuticals, Inc. compare | 21.4× |
| PTGX Protagonist Therapeutics, Inc. compare | 12.8× |
| SYRE Spyre Therapeutics, Inc. compare | 11.9× |
| TWST Twist Bioscience Corporation | 7.1× |
| TGTX TG Therapeutics, Inc. compare | 4.3× |
| CYTK Cytokinetics, Incorporated compare | 0.0× |
| CAI Caris Life Sciences,�Inc. compare | 0.0× |
| IBRX ImmunityBio, Inc. compare | −1.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on TWST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement